Senti Biosciences

formerly Senti BioIPO

Home - Senti Bio

Public · South San Francisco, United States · Founded 2016 · $205.6M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$205.6M
Last Round
$47.6M Corporate RoundDec 2024
Rounds
4
Type
Public

About

Senti Biosciences is a clinical-stage biotechnology company developing next-generation cell and gene therapies using proprietary Gene Circuit technology. Founded in 2016 and headquartered in South San Francisco, California, Senti Bio programs synthetic biology logic gates into cells to create smarter medicines for oncology and other incurable diseases.

Summary

Senti Biosciences is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $205.6M in total across 4 rounds, most recently a $47.6M Corporate Round round in Dec 2024. Investors include Celadon Partners, New Enterprise Associates and Leaps by Bayer.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundDec 2024
$47.6M

Sign up to see all 4 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Senti Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/senti-biosciences"><img src="https://indexed.vc/api/badge/company/senti-biosciences" alt="Senti Biosciences on Indexed.vc" width="260" height="76" /></a>